These are the sources and citations used to research H pylori. This bibliography was generated on Cite This For Me on

  • Journal

    Brown, L. M.

    Helicobacter Pylori: Epidemiology and Routes of Transmission

    2000 - Epidemiologic Reviews

    In-text: (Brown 283-297)

    Your Bibliography: Brown, L. M. "Helicobacter Pylori: Epidemiology And Routes Of Transmission." Epidemiologic Reviews 22.2 (2000): 283-297. Web.

  • Journal

    Camilleri, M.

    The role of pharmacogenetics in nonmalignant gastrointestinal diseases

    2012 - Nature Reviews Gastroenterology & Hepatology

    In-text: (Camilleri 173-184)

    Your Bibliography: Camilleri, Michael. "The Role Of Pharmacogenetics In Nonmalignant Gastrointestinal Diseases." Nature Reviews Gastroenterology & Hepatology 9.3 (2012): 173-184. Web.

  • Journal

    Chen, B., Luo, M., Zhou, X., Lv, Y. and Su, G.

    Correlation Between Interleukin-1β-511 C/T Polymorphism and Gastric Cancer in Chinese Populations: A Meta-Analysis

    2016 - Medical Science Monitor

    In-text: (Chen et al. 1742-1750)

    Your Bibliography: Chen, Bo et al. "Correlation Between Interleukin-1Β-511 C/T Polymorphism And Gastric Cancer In Chinese Populations: A Meta-Analysis." Medical Science Monitor 22 (2016): 1742-1750. Web.

  • Journal

    Chey, W. D., Leontiadis, G. I., Howden, C. W. and Moss, S. F.

    ACG Clinical Guideline: Treatment of Helicobacter pylori Infection

    2017 - American Journal of Gastroenterology

    In-text: (Chey et al. 212-239)

    Your Bibliography: Chey, William D et al. "ACG Clinical Guideline: Treatment Of Helicobacter Pylori Infection." American Journal of Gastroenterology 112.2 (2017): 212-239. Web.

  • Journal

    Dinarello, C. A.

    Overview of the IL-1 family in innate inflammation and acquired immunity

    2017 - Immunological Reviews

    In-text: (Dinarello 8-27)

    Your Bibliography: Dinarello, Charles A. "Overview Of The IL-1 Family In Innate Inflammation And Acquired Immunity." Immunological Reviews 281.1 (2017): 8-27. Web.

  • Journal

    Dunn, B. E., Cohen, H. and Blaser, M. J.

    Helicobacter pylori.

    1997 - Clinical microbiology reviews

    In-text: (Dunn, Cohen and Blaser 720-741)

    Your Bibliography: Dunn, B E, H Cohen, and M J Blaser. "Helicobacter Pylori.." Clinical microbiology reviews 10.4 (1997): 720-741. Web.

  • Journal

    Fallone, C. A., Chiba, N., van Zanten, S. V., Fischbach, L., Gisbert, J. P., Hunt, R. H., Jones, N. L., Render, C., Leontiadis, G. I., Moayyedi, P. and Marshall, J. K.

    The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults

    2016 - Gastroenterology

    In-text: (Fallone et al. 51-69.e14)

    Your Bibliography: Fallone, Carlo A. et al. "The Toronto Consensus For The Treatment Of Helicobacter Pylori Infection In Adults." Gastroenterology 151.1 (2016): 51-69.e14. Web.

  • Journal

    Fock, K., Katelaris, P., Sugano, K. and Ang, T.

    Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection

    2009 - J Gastroenterol Hepatol

    In-text: (Fock et al. 1587-600)

    Your Bibliography: Fock, KM et al. "Second Asia-Pacific Consensus Guidelines For Helicobacter Pylori Infection." J Gastroenterol Hepatol 24.10 (2009): 1587-600. Web. 30 Jan. 2020.

  • Journal

    Fock, K., Katelaris, P., Sugano, K. and Ang, T.

    Second Asia–Pacific Consensus Guidelines for Helicobacter pylori infection

    2009 - J Gastroenterol Hepatol

    In-text: (Fock et al. 1587-600)

    Your Bibliography: Fock, KM et al. "Second Asia–Pacific Consensus Guidelines For Helicobacter Pylori Infection." J Gastroenterol Hepatol 24.10 (2009): 1587-600. Web. 9 Feb. 2020.

  • Journal

    Furuta, T., Shirai, N., Xiao, F., El-Omar, E., Rabkin, C., Sugimura, H., Ishizaki, T. and Ohashi, K.

    Polymorphism of interleukin-1 beta affects the eradication rates of Helicobacter pylori by triple therapy

    2004 - Clin Gastroenterol Hepatol

    In-text: (Furuta et al. 22-30)

    Your Bibliography: Furuta, T et al. "Polymorphism Of Interleukin-1 Beta Affects The Eradication Rates Of Helicobacter Pylori By Triple Therapy." Clin Gastroenterol Hepatol 2.1 (2004): 22-30. Print.

  • Journal

    Furuta, T., Sugimoto, M., Shirai, N. and Matsushita, F.

    Effect of MDR1 C3435T polymorphism on cure rates of Helicobacter pylori infection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation to CYP 2C19 genotypes and 23S rRNA genotypes of H. pylori

    2007 - Alimentary Pharmacology & Therapeutics

    In-text: (Furuta et al. 693-703)

    Your Bibliography: Furuta, T. et al. "Effect Of MDR1 C3435T Polymorphism On Cure Rates Of Helicobacter Pylori Infection By Triple Therapy With Lansoprazole, Amoxicillin And Clarithromycin In Relation To CYP 2C19 Genotypes And 23S Rrna Genotypes Of H. Pylori." Alimentary Pharmacology & Therapeutics 26.5 (2007): 693-703. Web.

  • Journal

    Furuta, T., Ohashi, K., Kobayashi, K., Iida, I., Yoshida, H., Shirai, N., Takashima, M., Kosuge, K., Hanai, H., Chiba, K., Ishizaki, T. and Kaneko, E.

    Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humans

    1999 - Clinical Pharmacology & Therapeutics

    In-text: (Furuta et al. 265-274)

    Your Bibliography: Furuta, Takahisa et al. "Effects Of Clarithromycin On The Metabolism Of Omeprazole In Relation To CYP2C19 Genotype Status In Humans." Clinical Pharmacology & Therapeutics 66.3 (1999): 265-274. Web.

  • Journal

    Gatta, L., Vakil, N., Vaira, D. and Scarpignato, C.

    Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy

    2013 - BMJ

    In-text: (Gatta et al. f4587-f4587)

    Your Bibliography: Gatta, L. et al. "Global Eradication Rates For Helicobacter Pylori Infection: Systematic Review And Meta-Analysis Of Sequential Therapy." BMJ 347.aug07 1 (2013): f4587-f4587. Web.

  • Journal

    Gawrońska-Szklarz, B., Siuda, A., Kurzawski, M., Bielicki, D., Marlicz, W. and Droździk, M.

    Effects of CYP2C19, MDR1, and interleukin 1-B gene variants on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxicillin, and metronidazole

    2010 - European Journal of Clinical Pharmacology

    In-text: (Gawrońska-Szklarz et al. 681-687)

    Your Bibliography: Gawrońska-Szklarz, Barbara et al. "Effects Of CYP2C19, MDR1, And Interleukin 1-B Gene Variants On The Eradication Rate Of Helicobacter Pylori Infection By Triple Therapy With Pantoprazole, Amoxicillin, And Metronidazole." European Journal of Clinical Pharmacology 66.7 (2010): 681-687. Web.

  • Book

    Goodman, L. S., Gilman, A., Brunton, L. L., Hilal-Dandan, R. and Knollmann, B. C.

    Goodman & Gilman's the pharmacological basis of therapeutics

    2018 - McGraw Hill Education - New York [etc.]

    In-text: (Goodman et al. 928-938)

    Your Bibliography: Goodman, Louis Sanford et al. Goodman & Gilman's The Pharmacological Basis Of Therapeutics. 13th ed. New York [etc.]: McGraw Hill Education, 2018. Print.

  • Journal

    Hnatyszyn, A., Wielgus, K., Kaczmarek-Rys, M., Skrzypczak-Zielinska, M., Szalata, M., Mikolajczyk-Stecyna, J., Stanczyk, J., Dziuba, I., Mikstacki, A. and Slomski, R.

    Interleukin-1 Gene Polymorphisms in Chronic Gastritis Patients Infected with Helicobacter pylori as Risk Factors of Gastric Cancer Development

    2013 - Archivum Immunologiae et Therapiae Experimentalis

    In-text: (Hnatyszyn et al. 503-512)

    Your Bibliography: Hnatyszyn, Andrzej et al. "Interleukin-1 Gene Polymorphisms In Chronic Gastritis Patients Infected With Helicobacter Pylori As Risk Factors Of Gastric Cancer Development." Archivum Immunologiae et Therapiae Experimentalis 61.6 (2013): 503-512. Web.

  • Journal

    Hodges, L., Markova, S., Chinn, L. and Gow, J.

    Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)

    2009 - Pharmacogenetics and Genomics

    In-text: (Hodges et al. 152-161)

    Your Bibliography: Hodges, LM et al. "Very Important Pharmacogene Summary: ABCB1 (MDR1, P-Glycoprotein)." Pharmacogenetics and Genomics 21.3 (2009): 152-161. Web.

  • Journal

    Hong, J., Shu, X., Liu, D., Zhu, Y., Xie, C., Xie, Y., Zhang, K., Wang, A., Xiong, H., Zeng, H., Yu, H., Ma, J., Chen, Y., Zhu, X. and Lu, N.

    Antibiotic resistance and CYP2C19 polymorphisms affect the efficacy of concomitant therapies for Helicobacter pylori infection: an open-label, randomized, single-centre clinical trial

    2016 - Journal of Antimicrobial Chemotherapy

    In-text: (Hong et al. 2280-2285)

    Your Bibliography: Hong, Junbo et al. "Antibiotic Resistance And CYP2C19 Polymorphisms Affect The Efficacy Of Concomitant Therapies For Helicobacter Pylori Infection: An Open-Label, Randomized, Single-Centre Clinical Trial." Journal of Antimicrobial Chemotherapy 71.8 (2016): 2280-2285. Web.

  • Website

    Horn, J. and Hansten, P.

    Get to Know an Enzyme: CYP3A4


    In-text: (Horn and Hansten)

    Your Bibliography: Horn, JR, and PD Hansten. "Get To Know An Enzyme: CYP3A4." Pharmacy Times. N.p., 2008. Web. 9 Feb. 2020.

  • Journal

    Karaca, R. O., Kalkisim, S., Altinbas, A., Kilincalp, S., Yuksel, I., Goktas, M. T., Yasar, U., Bozkurt, A. and Babaoglu, M. O.

    Effects of Genetic Polymorphisms of Cytochrome P450 Enzymes and MDR1 Transporter on Pantoprazole Metabolism and Helicobacter pylori Eradication

    2016 - Basic & Clinical Pharmacology & Toxicology

    In-text: (Karaca et al. 199-206)

    Your Bibliography: Karaca, R Ozgur et al. "Effects Of Genetic Polymorphisms Of Cytochrome P450 Enzymes And MDR1 Transporter On Pantoprazole Metabolism And Helicobacter Pylori Eradication." Basic & Clinical Pharmacology & Toxicology 120.2 (2016): 199-206. Web.

  • Journal

    Kato, M., Ota, H., Okuda, M., Kikuchi, S., Satoh, K., Shimoyama, T., Suzuki, H., Handa, O., Furuta, T., Mabe, K., Murakami, K., Sugiyama, T., Uemura, N. and Takahashi, S.

    Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition

    2019 - Helicobacter

    In-text: (Kato et al. e12597)

    Your Bibliography: Kato, Mototsugu et al. "Guidelines For The Management Of Helicobacter Pylori Infection In Japan: 2016 Revised Edition." Helicobacter 24.4 (2019): e12597. Web.

  • Journal

    Klotz, U., Schwab, M. and Treiber, G.

    CYP2C19Polymorphism and Proton Pump Inhibitors

    2004 - Basic & Clinical Pharmacology & Toxicology

    In-text: (Klotz, Schwab and Treiber 2-8)

    Your Bibliography: Klotz, Ulrich, Matthias Schwab, and Gerhard Treiber. "Cyp2c19polymorphism And Proton Pump Inhibitors." Basic & Clinical Pharmacology & Toxicology 95.1 (2004): 2-8. Web.

  • Journal

    Li, M., Li, T., Guo, S., Liang, H. and Jiang, D.

    The effect of MDR1 C3435T polymorphism on the eradication rate of H. pylori infection in PPI-based triple therapy

    2017 - Medicine

    In-text: (Li et al. e6489)

    Your Bibliography: Li, Meng et al. "The Effect Of MDR1 C3435T Polymorphism On The Eradication Rate Of H. Pylori Infection In PPI-Based Triple Therapy." Medicine 96.13 (2017): e6489. Web.

  • Journal

    Liu, W. Z., Xie, Y., Lu, H., Cheng, H., Zeng, Z. R., Zhou, L. Y., Chen, Y., Wang, J. B., Du, Y. Q. and Lu, N. H.

    Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection

    2018 - Helicobacter

    In-text: (Liu et al. e12475)

    Your Bibliography: Liu, Wen Zhong et al. "Fifth Chinese National Consensus Report On The Management Of Helicobacter Pylori Infection." Helicobacter 23.2 (2018): e12475. Web.

  • Journal

    Luman, W.

    Helicobacter pylori: causation and treatment

    2005 - J R Coll Physicians Edinb

    In-text: (Luman 45-49)

    Your Bibliography: Luman, W. "Helicobacter Pylori: Causation And Treatment." J R Coll Physicians Edinb 35 (2005): 45-49. Print.

  • Journal

    Malfertheiner, P., Megraud, F., O'Morain, C. A., Atherton, J., Axon, A. T. R., Bazzoli, F., Gensini, G. F., Gisbert, J. P., Graham, D. Y., Rokkas, T., El-Omar, E. M. and Kuipers, E. J.

    Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report

    2017 - Gut

    In-text: (Malfertheiner et al. 6-30)

    Your Bibliography: Malfertheiner, Peter et al. "Management Of Helicobacter Pylori Infection—The Maastricht IV/ Florence Consensus Report." Gut 66.1 (2017): 6-30. Web.

  • Journal

    McNulty, C. A. M., Lasseter, G., Shaw, I., Nichols, T., D'Arcy, S., Lawson, A. J. and Glocker, E.

    Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered?

    2012 - Alimentary Pharmacology & Therapeutics

    In-text: (McNulty et al. 1221-1230)

    Your Bibliography: McNulty, C. A. M. et al. "Is Helicobacter Pylori Antibiotic Resistance Surveillance Needed And How Can It Be Delivered?." Alimentary Pharmacology & Therapeutics 35.10 (2012): 1221-1230. Web.

  • Website


    Drug Metabolism - The Importance of Cytochrome P450 3A4


    In-text: (Medsafe)

    Your Bibliography: Medsafe. "Drug Metabolism - The Importance Of Cytochrome P450 3A4." N.p., 2014. Web. 9 Feb. 2020.

  • Website


    Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management Clinical guideline CG184

    2014 - National Institute for Health and Care Excellence

    In-text: (NICE)

    Your Bibliography: NICE. "Gastro-Oesophageal Reflux Disease And Dyspepsia In Adults: Investigation And Management Clinical Guideline CG184." N.p., 2014. Web. 30 Jan. 2020.

  • Website


    2020 - Royal Dutch Pharmacists Association - Pharmacogenetics Working Group; Nov 2018 Update

    In-text: ("Pharmgkb")

    Your Bibliography: "Pharmgkb." PharmGKB. N.p., 2020. Web. 9 Feb. 2020.

  • Website


    Test and treat for Helicobacter pylori (HP) in dyspepsia. Quick reference guide for primary care: For consultation and local adaptation

    2019 - Public Health England

    In-text: (PHE)

    Your Bibliography: PHE. "Test And Treat For Helicobacter Pylori (HP) In Dyspepsia. Quick Reference Guide For Primary Care: For Consultation And Local Adaptation." N.p., 2019. Web. 30 Jan. 2020.

  • Journal

    Rawla, P. and Barsouk, A.

    Epidemiology of gastric cancer: global trends, risk factors and prevention

    2019 - Gastroenterology Review

    In-text: (Rawla and Barsouk 26-38)

    Your Bibliography: Rawla, Prashanth, and Adam Barsouk. "Epidemiology Of Gastric Cancer: Global Trends, Risk Factors And Prevention." Gastroenterology Review 14.1 (2019): 26-38. Web.

  • Journal

    Ren, H., Wen, L., Geng, Y., Huang, J., Liu, J., Shen, D. and Meng, J.

    Association between IL-1B gene polymorphisms and Helicobacter pylori infection: A meta-analysis

    2019 - Microbial Pathogenesis

    In-text: (Ren et al. 103769)

    Your Bibliography: Ren, Hong-Yue et al. "Association Between IL-1B Gene Polymorphisms And Helicobacter Pylori Infection: A Meta-Analysis." Microbial Pathogenesis 137 (2019): 103769. Web.

  • Journal

    Rodrigues, A., Roberts, E., Mulford, D., Yao, Y. and Ouellet, D.

    Oxidative metabolism of clarithromycin in the presence of human liver microsome: major role for the cytochrome P4503A (CYP3A) subfamily

    1997 - Drug Metab Dispos

    In-text: (Rodrigues et al. 623-30)

    Your Bibliography: Rodrigues, AD et al. "Oxidative Metabolism Of Clarithromycin In The Presence Of Human Liver Microsome: Major Role For The Cytochrome P4503A (CYP3A) Subfamily." Drug Metab Dispos 25 (1997): 623-30. Print.

  • Journal

    Sachs, G., Scott, D. R. and Wen, Y.

    Gastric Infection by Helicobacter pylori

    2011 - Current Gastroenterology Reports

    In-text: (Sachs, Scott and Wen 540-546)

    Your Bibliography: Sachs, George, David R. Scott, and Yi Wen. "Gastric Infection By Helicobacter Pylori." Current Gastroenterology Reports 13.6 (2011): 540-546. Web.

  • Journal

    Sapone, A., Vaira, D., Trespidi, S., Perna, F., Gatta, L., Tampieri, A., Ricci, C., Cantelli-Forti, G., Miglioli, M., Biagi, G. L. and Paolini, M.

    The clinical role of cytochrome p450 genotypes in Helicobacter pylori management

    2003 - The American Journal of Gastroenterology

    In-text: (Sapone et al. 1010-1015)

    Your Bibliography: Sapone, A. et al. "The Clinical Role Of Cytochrome P450 Genotypes In Helicobacter Pylori Management." The American Journal of Gastroenterology 98.5 (2003): 1010-1015. Web.

  • Journal

    Shin, J. M. and Sachs, G.

    Pharmacology of proton pump inhibitors

    2008 - Current Gastroenterology Reports

    In-text: (Shin and Sachs 528-534)

    Your Bibliography: Shin, Jai Moo, and George Sachs. "Pharmacology Of Proton Pump Inhibitors." Current Gastroenterology Reports 10.6 (2008): 528-534. Web.

  • Journal

    Shin, J. M. and Kim, N.

    Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors

    2013 - Journal of Neurogastroenterology and Motility

    In-text: (Shin and Kim 25-35)

    Your Bibliography: Shin, Jai Moo, and Nayoung Kim. "Pharmacokinetics And Pharmacodynamics Of The Proton Pump Inhibitors." Journal of Neurogastroenterology and Motility 19.1 (2013): 25-35. Web.

  • Website

    Stomach cancer statistics

    2020 - Cancer Research UK

    In-text: ("Stomach Cancer Statistics")

    Your Bibliography: "Stomach Cancer Statistics." Cancer Research UK. N.p., 2020. Web. 30 Jan. 2020.

  • Journal

    Sung, J. J. Y., Kuipers, E. J. and El-Serag, H. B.

    Systematic review: the global incidence and prevalence of peptic ulcer disease

    2009 - Alimentary Pharmacology & Therapeutics

    In-text: (Sung, Kuipers and El-Serag 938-946)

    Your Bibliography: Sung, J. J. Y., E. J. Kuipers, and H. B. El-Serag. "Systematic Review: The Global Incidence And Prevalence Of Peptic Ulcer Disease." Alimentary Pharmacology & Therapeutics 29.9 (2009): 938-946. Web.

  • Journal

    Take, S., Mizuno, M., Ishiki, K., Nagahara, Y., Yoshida, T., Inaba, T., Yamamoto, K., Okada, H., Yokota, K., Oguma, K. and Shiratori, Y.

    Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection

    2003 - The American Journal of Gastroenterology

    In-text: (Take et al. 2403-2408)

    Your Bibliography: Take, Susumu et al. "Interleukin-1Beta Genetic Polymorphism Influences The Effect Of Cytochrome P 2C19 Genotype On The Cure Rate Of 1-Week Triple Therapy For Helicobacter Pylori Infection." The American Journal of Gastroenterology 98.11 (2003): 2403-2408. Web.

  • Journal

    Tan, P. and Yeoh, K.

    Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma

    2015 - Gastroenterology

    In-text: (Tan and Yeoh 1153-1162.e3)

    Your Bibliography: Tan, Patrick, and Khay-Guan Yeoh. "Genetics And Molecular Pathogenesis Of Gastric Adenocarcinoma." Gastroenterology 149.5 (2015): 1153-1162.e3. Web.

  • Journal

    Ullrich, A., Fischbach, W. and Blettner, M.

    Incidence of gastric B-cell lymphomas: a population-based study in Germany

    2002 - Annals of Oncology

    In-text: (Ullrich, Fischbach and Blettner 1120-1127)

    Your Bibliography: Ullrich, A., W. Fischbach, and M. Blettner. "Incidence Of Gastric B-Cell Lymphomas: A Population-Based Study In Germany." Annals of Oncology 13.7 (2002): 1120-1127. Web.

  • Journal

    Weck, M. N.

    Prevalence of Chronic Atrophic Gastritis in Different Parts of the World

    2006 - Cancer Epidemiology Biomarkers & Prevention

    In-text: (Weck 1083-1094)

    Your Bibliography: Weck, M. N. "Prevalence Of Chronic Atrophic Gastritis In Different Parts Of The World." Cancer Epidemiology Biomarkers & Prevention 15.6 (2006): 1083-1094. Web.

  • Journal

    Yaxley, J. and Chakravarty, B.

    Helicobacter pylori eradication - an update on the latest therapies

    2014 - Australian Family Physician

    In-text: (Yaxley and Chakravarty 301-5)

    Your Bibliography: Yaxley, J, and B Chakravarty. "Helicobacter Pylori Eradication - An Update On The Latest Therapies." Australian Family Physician 43.5 (2014): 301-5. Print.

  • Journal

    Zvyaga, T., Chang, S., Chen, C., Yang, Z., Vuppugalla, R., Hurley, J., Thorndike, D., Wagner, A., Chimalakonda, A. and Rodrigues, A. D.

    Evaluation of Six Proton Pump Inhibitors As Inhibitors of Various Human Cytochromes P450: Focus on Cytochrome P450 2C19

    2012 - Drug Metabolism and Disposition

    In-text: (Zvyaga et al. 1698-1711)

    Your Bibliography: Zvyaga, Tatyana et al. "Evaluation Of Six Proton Pump Inhibitors As Inhibitors Of Various Human Cytochromes P450: Focus On Cytochrome P450 2C19." Drug Metabolism and Disposition 40.9 (2012): 1698-1711. Web.

Click here to start building your own bibliography
Keep on Citing!
Cite This For Me:
The Easiest Tool to Create your Bibliographies Online
Join Us!

Save Time and Improve Your Marks with Cite This For Me

10,587 students joined last month!

  • ✔ Save your bibliographies for longer
  • ✔ Super fast and accurate citation program
  • ✔ Save time when referencing
  • ✔ Make your student life easy and fun
  • ✔ Pay only once with our Forever plan
  • ✔ Use plagiarism checker
  • ✔ Create and edit multiple bibliographies